Taikun Pharmaceutical Technology SA
Taikun Pharmaceutical Technology reported total assets of 275,396 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).
The score of Taikun Pharmaceutical Technology shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Taikun Pharmaceutical Technology's annual accounts
| 2025 | |
|---|---|
| Net result | −161,100 € |
| Equity | 138,900 € |
| Cash | 200,754 € |
| EBITDA | −160,830 € |
| Total assets | 275,396 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
Taikun Pharmaceutical Technology's financial analysis
- Solvency50.4%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Taikun Pharmaceutical Technology
6 active director(s) in the register.
Taikun Pharmaceutical Technology's shareholders and holdings →Taikun Pharmaceutical Technology's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1007.641.938
- VAT number
- BE1007641938
- Peppol
- Registered · 0208:1007641938 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Mar 2024
- Registered office
- 9052 Ghent
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Taikun Pharmaceutical Technology (SA) has been based in Ghent since 2024, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 161,100 € and equity of 138,900 €; its revenue is not published. Its solvency stands at 50.4%, below the median of its sector (56.0%).
Companies similar to Taikun Pharmaceutical Technology
Companies in the same business, of comparable size and area, outside its group.
- JCM Dental Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet 276,276 €
- Hexacath Belgium Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 96,025 €
- Congress Pharma Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet 82,571 €
- DJB Medical Wholesale of pharmaceutical and medical goods Merchtem · balance sheet 406,739 €
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- LHP Healthcare Wholesale of pharmaceutical and medical goods Seraing · balance sheet 520,810 €
- Van de Ghoor Wholesale of pharmaceutical and medical goods Beringen · balance sheet 346,700 €
- Alnylam Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.20m
Frequently asked questions about Taikun Pharmaceutical Technology
What is the revenue of Taikun Pharmaceutical Technology?
Taikun Pharmaceutical Technology files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Taikun Pharmaceutical Technology?
In Belgium, the VAT number is the company number prefixed with BE: BE1007641938 for Taikun Pharmaceutical Technology, if the company is VAT-registered. Its company number (CBE) is 1007.641.938.
Where is the registered office of Taikun Pharmaceutical Technology?
According to the CBE register, the registered office of Taikun Pharmaceutical Technology is in 9052 Ghent.
What is the equity of Taikun Pharmaceutical Technology?
At the close of the 2025 financial year, the equity of Taikun Pharmaceutical Technology amounts to 138,900 €, a solvency of 50.4% of total assets.
Who manages Taikun Pharmaceutical Technology?
The register lists 6 active mandates at Taikun Pharmaceutical Technology. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Taikun Pharmaceutical Technology
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →